GGlobal Biosimilar Drug Development: Any Chance for Consolidation after 15 Years of Positive Regulatory Experience? / Zsolt Holló
Bibliogr.: p. 139. - DOI: https://doi.org/10.33892/aph.2021.91.138-139
In: Acta Pharmaceutica Hungarica. - ISSN 0001-6659. - 2021. 91. évf. 3-4. sz., p. 138-139.
Kulcsszavak: biosimilar, comparability, regulatory framework, interchangeability, access
